ConductScience.org, home

Paper20165580

Can alternative medicine do better than placebo?: Does it even matter?

Moyad MA. Can Urol Assoc J, 2010. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Can alternative medicine do better than placebo?: Does it even matter? Papers, record 20165580. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20165580

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Can alternative medicine do better than placebo?: Does it even matter?
PubMed
Journal
Can Urol Assoc J
PubMed
Year
2010
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0
iCite
Revised in PubMed
2021-10-20
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Moyad MAMark A

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References19

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115656714Monograph. Angelica sinensis.Altern Med Rev2004https://conductscience.org/library/papers/15656714PubMed
219025432Increased risk of metabolic syndrome, diabetes mellitus, and cardiovascular disease in men receiving androgen deprivation therapy for prostate cancer.Pharmacotherapy2008https://conductscience.org/library/papers/19025432PubMed
316323982Antiandrogenic therapy can cause coronary arterial disease.Int J Urol2005https://conductscience.org/library/papers/16323982PubMed
419731578Comparison of objective and patient-reported hot flash measures in men with prostate cancer.J Support Oncol2009https://conductscience.org/library/papers/19731578PubMed
516278617Use of dong quai (Angelica sinensis) to treat peri- or postmenopausal symptoms in women with breast cancer: is it appropriate?Menopause2005https://conductscience.org/library/papers/16278617PubMed
619064574Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery.Cancer Epidemiol Biomarkers Prev2008https://conductscience.org/library/papers/19064574PubMed
715885584Promoting general health during androgen deprivation therapy (ADT): a rapid 10-step review for your patients.Urol Oncol2005https://conductscience.org/library/papers/15885584PubMed
817179056Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial.Ann Intern Med2006https://conductscience.org/library/papers/17179056PubMed
912109340The placebo effect and randomized trials: analysis of conventional medicine.Urol Clin North Am2002https://conductscience.org/library/papers/12109340PubMed
1016006929Parenteral medroxyprogesterone for the management of luteinizing hormone releasing hormone induced hot flashes in men with advanced prostate cancer.J Urol2005https://conductscience.org/library/papers/16006929PubMed
1119129205A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB).Ann Oncol2009https://conductscience.org/library/papers/19129205PubMed
1219963436
Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial.
Lancet Oncol2010https://conductscience.org/library/papers/19963436PubMed
1317593379Non-hormonal therapy of post-menopausal vasomotor symptoms: a structured evidence-based review.Arch Gynecol Obstet2007https://conductscience.org/library/papers/17593379PubMed
149418683Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial.Fertil Steril1997https://conductscience.org/library/papers/9418683PubMed
1516139656Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial.Lancet2005https://conductscience.org/library/papers/16139656PubMed
1619515737Meta-analysis of the effects of flaxseed interventions on blood lipids.Am J Clin Nutr2009https://conductscience.org/library/papers/19515737PubMed
1717472816Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review.Clin Ther2007https://conductscience.org/library/papers/17472816PubMed
1820165579Dong Quai (angelica sinensis) in the treatment of hot flashes for men on androgen deprivation therapy: results of a randomized double-blind placebo controlled trial.Can Urol Assoc J2010https://conductscience.org/library/papers/20165579PubMed
1911937433Complementary/alternative therapies for reducing hot flashes in prostate cancer patients: reevaluating the existing indirect data from studies of breast cancer and postmenopausal women.Urology2002https://conductscience.org/library/papers/11937433PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20165580

GET https://conductscience.org/api/papers/v1/20165580/authors